MX2011006290A - Compuestos de aza-azuleno. - Google Patents

Compuestos de aza-azuleno.

Info

Publication number
MX2011006290A
MX2011006290A MX2011006290A MX2011006290A MX2011006290A MX 2011006290 A MX2011006290 A MX 2011006290A MX 2011006290 A MX2011006290 A MX 2011006290A MX 2011006290 A MX2011006290 A MX 2011006290A MX 2011006290 A MX2011006290 A MX 2011006290A
Authority
MX
Mexico
Prior art keywords
compounds
azaazulene compounds
azaazulene
pks
modulate
Prior art date
Application number
MX2011006290A
Other languages
English (en)
Inventor
On Lee
Chih-Hung Chen
Chi-Y Hung
Yow-Lone Chang
Ting-Shou Chen
Original Assignee
Ind Tech Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ind Tech Res Inst filed Critical Ind Tech Res Inst
Publication of MX2011006290A publication Critical patent/MX2011006290A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Se proporcionan compuestos de aza-azuleno de la Fórmula (I). Los compuestos mencionados pueden ser usados para modular a las proteínas quinasas (PKs) y/o para tratar cáncer.
MX2011006290A 2009-04-29 2010-04-29 Compuestos de aza-azuleno. MX2011006290A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17388309P 2009-04-29 2009-04-29
PCT/CN2010/072342 WO2010124648A1 (en) 2009-04-29 2010-04-29 Azaazulene compounds

Publications (1)

Publication Number Publication Date
MX2011006290A true MX2011006290A (es) 2011-09-28

Family

ID=43030852

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011006290A MX2011006290A (es) 2009-04-29 2010-04-29 Compuestos de aza-azuleno.

Country Status (15)

Country Link
US (1) US8492374B2 (es)
EP (1) EP2491025B1 (es)
JP (1) JP5538522B2 (es)
KR (1) KR101278826B1 (es)
CN (1) CN102405217B (es)
AU (1) AU2010244019B2 (es)
BR (1) BRPI1005525A2 (es)
CA (1) CA2747420C (es)
ES (1) ES2443870T3 (es)
IL (1) IL213019A (es)
MX (1) MX2011006290A (es)
NZ (1) NZ593004A (es)
RU (1) RU2524202C9 (es)
TW (1) TWI410418B (es)
WO (1) WO2010124648A1 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5712524B2 (ja) * 2009-10-28 2015-05-07 Jsr株式会社 液晶配向剤および液晶表示素子
KR102132405B1 (ko) 2010-05-20 2020-07-09 어레이 바이오파마 인크. Trk 키나제 저해제로서의 매크로시클릭 화합물
CN102558096B (zh) * 2010-12-30 2015-01-21 达兴材料股份有限公司 芳香族二胺化合物、使用此芳香族二胺化合物制备的聚酰胺酸与聚酰亚胺以及液晶配向剂
KR101668514B1 (ko) * 2011-02-25 2016-10-21 머크 샤프 앤드 돔 코포레이션 항당뇨병제로서 유용한 신규 시클릭 아자벤즈이미다졸 유도체
GB2499666A (en) * 2012-02-27 2013-08-28 Nanyang Polytechnic Mcl-1 inhibitors for the treatment of conditions associated with proliferative disorders
JP5949070B2 (ja) * 2012-04-03 2016-07-06 Jsr株式会社 液晶配向剤、液晶配向膜及び液晶表示素子
TWI443096B (zh) * 2012-12-18 2014-07-01 Ind Tech Res Inst ３－（５－（４－（３－氟丙基）哌嗪－１－基）苯並咪唑－２－基）－１－氮雜薁－２－酮之單水合晶型及其製備方法與藥學組成物
JPWO2016068099A1 (ja) * 2014-10-28 2017-08-10 塩野義製薬株式会社 Ａｍｐｋ活性化作用を有する複素環誘導体
LT3322706T (lt) 2015-07-16 2021-03-10 Array Biopharma, Inc. Pakeistieji pirazolo[1,5-a]piridino junginiai, kaip ret kinazės inhibitoriai
TWI704148B (zh) 2016-10-10 2020-09-11 美商亞雷生物製藥股份有限公司 作為ｒｅｔ激酶抑制劑之經取代吡唑并[1,5-a]吡啶化合物
JOP20190077A1 (ar) 2016-10-10 2019-04-09 Array Biopharma Inc مركبات بيرازولو [1، 5-a]بيريدين بها استبدال كمثبطات كيناز ret
CA3049136C (en) 2017-01-18 2022-06-14 Array Biopharma Inc. Substituted pyrazolo[1,5-a]pyrazine compounds as ret kinase inhibitors
WO2018136663A1 (en) 2017-01-18 2018-07-26 Array Biopharma, Inc. Ret inhibitors
JOP20190213A1 (ar) 2017-03-16 2019-09-16 Array Biopharma Inc مركبات حلقية ضخمة كمثبطات لكيناز ros1
EP3668867B1 (en) * 2017-08-18 2023-10-04 Universität Regensburg Synthesis, pharmacology and use of new and selective fms-like tyrosine kinase 3 (flt3) flt3 inhibitors
IL273658B1 (en) * 2017-10-04 2024-06-01 Celgene Corp Compounds and methods for using cis-4-[2-{[(3S,4R)-3-fluoroxan-4-YL]amino}-8-(2,4,6-trichloroanilino)-9H-purine-9-YL]- 1-Methylcyclohexane-1-carboxamide
TW202410896A (zh) 2017-10-10 2024-03-16 美商絡速藥業公司 6-(2-羥基-2-甲基丙氧基)-4-(6-(6-((6-甲氧基吡啶-3-基)甲基)-3,6-二氮雜雙環[3.1.1]庚-3-基)吡啶-3-基)吡唑并[1,5-a]吡啶-3-甲腈之調配物
TWI791053B (zh) 2017-10-10 2023-02-01 美商亞雷生物製藥股份有限公司 6-(2-羥基-2-甲基丙氧基)-4-(6-(6-((6-甲氧基吡啶-3-基)甲基)-3,6-二氮雜雙環[3.1.1]庚-3-基)吡啶-3-基)吡唑并[1,5-a]吡啶-3-甲腈之結晶形式及其醫藥組合物
JP7060694B2 (ja) 2018-01-18 2022-04-26 アレイ バイオファーマ インコーポレイテッド Ｒｅｔキナーゼ阻害剤としての置換ピロロ［２，３－ｄ］ピリミジン化合物
US11524963B2 (en) 2018-01-18 2022-12-13 Array Biopharma Inc. Substituted pyrazolo[3,4-d]pyrimidines as RET kinase inhibitors
JP6997876B2 (ja) 2018-01-18 2022-02-04 アレイ バイオファーマ インコーポレイテッド Ｒｅｔキナーゼ阻害剤としての置換ピラゾリル［４，３－ｃ］ピリジン化合物
US11964988B2 (en) 2018-09-10 2024-04-23 Array Biopharma Inc. Fused heterocyclic compounds as RET kinase inhibitors
CN113490668A (zh) 2018-10-05 2021-10-08 安娜普尔纳生物股份有限公司 用于治疗与apj受体活性有关的疾病的化合物和组合物
WO2020231739A2 (en) * 2019-05-10 2020-11-19 Antidote Ip Holdings, Llc Compounds and methods for treating cancer

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3230234A (en) * 1960-05-06 1966-01-18 Sankyo Co Process for the preparation of 2, 3-dihydro-1h-cyclohepta [b] pyrrole-2, 8-dione derivatives and products thereof
US3113950A (en) * 1960-05-06 1963-12-10 Sankyo Co Process for the preparation of cyclohepta [b] pyrrol-8(1h)-one derivatives
US3311641A (en) * 1963-06-22 1967-03-28 Sankyo Co Hydrohalides of novel cyclohepta[b]-pyrrole derivatives and a process for preparing the same as well as intermediates and process for their preparations
US4337265A (en) * 1981-08-21 1982-06-29 Ayerst, Mckenna & Harrison Inc. Cyclohepta[b]pyrrole derivatives
JPH02178263A (ja) 1988-12-27 1990-07-11 Kaken Pharmaceut Co Ltd アザアズレン誘導体、その製造法およびそれを有効成分とする抗アレルギー剤および抗炎症剤
DE68926032T2 (de) 1988-12-29 1996-09-05 Seiko Instr Inc Ansteuersystem für ein Anzeigegerät
USRE34198E (en) * 1989-03-10 1993-03-23 Gate Pallet Systems, Inc. Corrugated construction pallet
DE60018782T2 (de) * 1999-10-19 2006-04-06 Merck & Co., Inc. Tyrosin kinase inhibitoren
US6794393B1 (en) * 1999-10-19 2004-09-21 Merck & Co., Inc. Tyrosine kinase inhibitors
EE05107B1 (et) 1999-10-19 2008-12-15 Merck & Co., Inc. Türosiinkinaasi pärssiv ühend, seda sisaldav farmatseutiline kompositsioon ning ühendi kasutamine
WO2001057018A1 (en) 2000-02-02 2001-08-09 Abbott Laboratories Azaazulene inhibitors of p38 map kinase and tnf-alpha
EP1650203B1 (en) 2000-09-11 2008-02-20 Novartis Vaccines and Diagnostics, Inc. Process of preparation of benzimidazol-2-yl quinolinone derivatives
WO2003004488A1 (en) * 2001-07-03 2003-01-16 Chiron Corporation Indazole benzimidazole compounds as tyrosine and serine/threonine kinase inhibitors
AU2003288899B2 (en) 2002-08-23 2009-09-03 Novartis Vaccines And Diagnostics, Inc. Benzimidazole quinolinones and uses thereof
ATE420881T1 (de) * 2003-09-17 2009-01-15 Janssen Pharmaceutica Nv Kondensierte heterocyclische verbindungen als modulatoren des serotoninrezeptors
JP5019884B2 (ja) 2004-02-20 2012-09-05 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド 炎症プロセスおよび転移プロセスの調節
TW200605885A (en) 2004-07-29 2006-02-16 Threshold Pharmaceuticals Inc Multicyclic lonidamine analogs
DK1885187T3 (da) 2005-05-13 2013-12-09 Novartis Ag Fremgangsmåde til behandling af lægemiddelresistent cancer
CA2651549A1 (en) * 2006-05-26 2007-12-06 Novartis Ag Aldosterone synthase and/or 11.beta.-hydroxylase inhibitors
JP4937881B2 (ja) * 2006-11-01 2012-05-23 財団法人工業技術研究院 アズレン化合物
WO2008108941A2 (en) * 2007-03-01 2008-09-12 Mallinckrodt Inc. Integrated photoactive peptides and uses thereof
RU2009136669A (ru) 2007-03-09 2011-04-20 Новартис АГ (CH) Лечение меланомы
WO2008150899A1 (en) 2007-05-29 2008-12-11 Emory University Combination therapies for treatment of cancer and inflammatory diseases

Also Published As

Publication number Publication date
TW201038556A (en) 2010-11-01
EP2491025B1 (en) 2013-11-27
KR20110098738A (ko) 2011-09-01
NZ593004A (en) 2013-05-31
JP5538522B2 (ja) 2014-07-02
KR101278826B1 (ko) 2013-06-25
US8492374B2 (en) 2013-07-23
RU2011122916A (ru) 2013-06-10
JP2012524032A (ja) 2012-10-11
EP2491025A1 (en) 2012-08-29
RU2524202C2 (ru) 2014-07-27
IL213019A0 (en) 2011-07-31
IL213019A (en) 2014-07-31
CN102405217B (zh) 2014-06-11
WO2010124648A1 (en) 2010-11-04
CA2747420C (en) 2013-09-10
RU2524202C9 (ru) 2015-06-10
BRPI1005525A2 (pt) 2016-02-23
AU2010244019B2 (en) 2012-05-10
CN102405217A (zh) 2012-04-04
TWI410418B (zh) 2013-10-01
EP2491025A4 (en) 2013-01-23
US20100280012A1 (en) 2010-11-04
CA2747420A1 (en) 2010-11-04
AU2010244019A1 (en) 2010-11-04
ES2443870T3 (es) 2014-02-20

Similar Documents

Publication Publication Date Title
MX2011006290A (es) Compuestos de aza-azuleno.
MX342274B (es) Actividades de la piruvato quinasa m2 (pkm2).
IN2012DN00471A (es)
MX2010009765A (es) Moleculas pequeñas que contienen boro como agentes anti-inflamatorios.
MY184101A (en) Indoles
JO2788B1 (en) Amido phenoxyendazole compounds beneficial as C-MET inhibitors
MY160399A (en) Compounds, compositions, and methods for preventing metastasis of cancer cells
IN2012DN00692A (es)
MX2012001618A (es) Derivados de 5-fluoropirimidinona.
MX2009012623A (es) Moduladores de cinasa heterociclicos.
MY160390A (en) Vinyl indazolyl compounds
EP2429292A4 (en) COMPOUNDS AND COMPOSITIONS WITH CDK INHIBITORS AND METHOD FOR THE TREATMENT OF CANCER
MX2014012477A (es) Inhibidores pirrolopirazona de tanquirasa.
MX2011011431A (es) Composicion para el tratamiento de cancer de prostata.
NZ707778A (en) Therapeutic compounds and compositions and their use as pkm2 modulators
MX336022B (es) Activadores de pkm2 bicíclicos.
MX2012001620A (es) Derivados de n1-acil-5-fluoropirimidinona.
MX2014008864A (es) Derivados de triazolo[4,5-d]pirimidina.
MX2013015357A (es) Terapia de combinacion.
MX342239B (es) Composiciones y metodos para el diagnostico y tratamiento de tumores.
PT3330383T (pt) Grn163l para utiliização como inibidor de telomerase no tratamento de cancro
MX2011006532A (es) Compuestos anticancerigenos.
TN2012000381A1 (en) 2-aldoximino-5-fluoropyrimidine derivatives
WO2012037553A9 (en) Use of pkc-iota inhibitors for the treatment of breast cancer
MY159995A (en) Pyrimidinyl indole compounds

Legal Events

Date Code Title Description
FG Grant or registration